A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Phase 2
Terminated
- Conditions
- Chronic Peripheral Neuropathy Pain in Diabetics
- Interventions
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2009-06-30
- Lead Sponsor
- XTL Biopharmaceuticals
- Target Recruit Count
- 250
- Registration Number
- NCT00597649
- Locations
- ๐บ๐ธ
Four Rivers Clinical Research, Paducah, Kentucky, United States
Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2007-11-04
- Lead Sponsor
- XTL Biopharmaceuticals
- Target Recruit Count
- 336
- Registration Number
- NCT00553592
- Locations
- ๐บ๐ธ
Four Rivers Clinical Research, Paducah, Kentucky, United States
Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection
Phase 1
- Conditions
- Hepatitis C
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2007-03-07
- Lead Sponsor
- XTL Biopharmaceuticals
- Target Recruit Count
- 36
- Registration Number
- NCT00300807
- Locations
- ๐บ๐ธ
Mt Sinai School of Medicine, New York, New York, United States
๐บ๐ธUniversity Of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
๐ฎ๐ฑHadassah University Hospital, Jerusalem, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath